Sharp Therapeutics Corp. (TSXV:SHRX)
Canada · Delayed Price · Currency is CAD 1.370
0.00 (0.00%)
At close: Sep 8, 2026
Sharp Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 0.1 | 0.96 | 3.48 | 0.38 | 0.16 |
Cash & Short-Term Investments | 0.1 | 0.96 | 3.48 | 0.38 | 0.16 |
Cash Growth | -96.68% | -72.55% | 824.64% | 129.45% | - |
Prepaid Expenses | 0.05 | 0.06 | 0.03 | 0.05 | 0.03 |
Total Current Assets | 0.15 | 1.02 | 3.52 | 0.43 | 0.2 |
Property, Plant & Equipment | 0.88 | 0.92 | 1.02 | 1.1 | 1.21 |
Other Long-Term Assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Total Assets | 1.04 | 1.95 | 4.55 | 1.55 | 1.42 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 0.27 | 0.29 | 0.27 | 0.18 | 0.1 |
Accrued Expenses | 0.7 | 0.55 | 0.25 | 0.23 | 0.13 |
Current Portion of Long-Term Debt | - | - | - | 7.28 | 3.94 |
Current Portion of Leases | 0.22 | 0.11 | 0.04 | 0.03 | 0.03 |
Other Current Liabilities | - | - | 0.13 | - | - |
Total Current Liabilities | 2.19 | 0.95 | 0.69 | 7.72 | 4.2 |
Long-Term Debt | - | - | - | 3.97 | 3.8 |
Long-Term Leases | 1.03 | 1.17 | 1.28 | 1.32 | 1.34 |
Other Long-Term Liabilities | - | - | - | 0.02 | 0.02 |
Total Liabilities | 3.22 | 2.13 | 1.97 | 13.03 | 9.37 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 25 | 25 | 21.79 | 4.55 | 4.55 |
Additional Paid-In Capital | 1.37 | 0.92 | 0.67 | 0.59 | 0.56 |
Retained Earnings | -28.51 | -26.06 | -19.89 | -16.62 | -13.06 |
Comprehensive Income & Other | -0.04 | -0.04 | 0.01 | - | - |
Shareholders' Equity | -2.18 | -0.18 | 2.58 | -11.48 | -7.95 |
Total Liabilities & Equity | 1.04 | 1.95 | 4.55 | 1.55 | 1.42 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 2.26 | 1.28 | 1.32 | 12.6 | 9.11 |
Net Cash (Debt) | -2.15 | -0.33 | 2.17 | -12.22 | -8.95 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.07 | -0.01 | 0.24 | -2.81 | -64.45 |
Filing Date Shares Outstanding | 31.58 | 30.08 | 29.94 | 0.14 | 0.14 |
Total Common Shares Outstanding | 30.08 | 30.08 | 28.22 | 0.14 | 0.14 |
Working Capital | -2.04 | 0.06 | 2.83 | -7.29 | -4.01 |
Book Value Per Share | -0.07 | -0.01 | 0.09 | -82.45 | -57.25 |
Tangible Book Value | -2.18 | -0.18 | 2.58 | -11.48 | -7.95 |
Tangible Book Value Per Share | -0.07 | -0.01 | 0.09 | -82.45 | -57.25 |
Machinery | 0.2 | 0.2 | 0.2 | 0.19 | 0.18 |
Leasehold Improvements | 0.01 | 0.01 | 0.01 | 0.01 | - |